(Q37034614)

17 August 2017

1 reference

title

HIV-1 integrase inhibitors: update and perspectives (English)

1 reference

17 August 2017

0 references

3

Yves Pommier

1 reference

17 August 2017

Elena A Semenova

1

1 reference

PubMed ID

18086413

17 August 2017

Christophe Marchand

series ordinal

2

1 reference

17 August 2017

1 January 2008

1 reference

17 August 2017

Advances in Pharmacology

1 reference

17 August 2017

56

1 reference

17 August 2017

199-228

1 reference

Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Discovery of a small-molecule HIV-1 integrase inhibitor-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Disulfide-linked integrase oligomers involving C280 residues are formed in vitro and in vivo but are not essential for human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

High-resolution structure of the catalytic domain of avian sarcoma virus integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Solution structure of the N-terminal zinc binding domain of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

High-level expression of active HIV-1 integrase from a synthetic gene in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Structure and function of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Reversal of Integration and DNA Splicing Mediated by Integrase of Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

A role for LEDGF/p75 in targeting HIV DNA integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

A rapid in vitro assay for HIV DNA integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

HIV-1 integrase inhibitors: 2003-2004 update

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Mining the NCI antiviral compounds for HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Identification of a nucleotide binding site in HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibitors of human immunodeficiency virus integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Development of an acid-soluble assay for measuring retrovirus integrase 3'-OH terminal nuclease activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

A 32,000-Dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Isolation, structure, absolute stereochemistry, and HIV-1 integrase inhibitory activity of integrasone, a novel fungal polyketide.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Heterogeneity in recombinant HIV-1 integrase corrected by site-directed mutagenesis: the identification and elimination of a protease cleavage site.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Requirement of the avian retrovirus pp32 DNA binding protein domain for replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Probing HIV-1 Integrase Inhibitor Binding Sites with Position-Specific Integrase-DNA Cross-Linking Assays

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Design and synthesis of dimeric HIV-1 integrase inhibitory peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

An essential role for LEDGF/p75 in HIV integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Lys-34, dispensable for integrase catalysis, is required for preintegration complex function and human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

In vitro human immunodeficiency virus type 1 integrase assays

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Mechanisms and inhibition of HIV integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Design, synthesis, and anti-integrase activity of catechol-DKA hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Nuclear import of HIV-1 integrase is inhibited in vitro by styrylquinoline derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Lack of infectivity of HIV-1 integrase zinc finger-like domain mutant with morphologically normal maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Potent inhibitors of human immunodeficiency virus type 1 integrase: identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Structural analysis of a mutant of the HIV-1 integrase zinc finger domain that forms a single conformation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Globoidnan A: a lignan from Eucalyptus globoidea inhibits HIV integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Mutations in the HIV type 1 integrase of patients receiving long-term dideoxynucleoside therapy do not confer resistance to zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Interfacial inhibitors of protein-nucleic acid interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Inhibitors of human immunodeficiency virus integrase.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Integrase inhibitors to treat HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Reversion of the lethal phenotype of an HIV-1 integrase mutant virus by overexpression of the same integrase mutant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Mode of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Thalassiolins A-C: new marine-derived inhibitors of HIV cDNA integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Novel HIV-1 integrase inhibitors derived from quinolone antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

A historical sketch of the discovery and development of HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Preferential inhibition of the magnesium-dependent strand transfer reaction of HIV-1 integrase by alpha-hydroxytropolones

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Integration of human immunodeficiency virus as a target for antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Fungal phenalenones inhibit HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Basics of the virology of HIV-1 and its replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Cellular co-factors of HIV-1 integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

The human immunodeficiency virus integrase protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Analysis of the junctions between human immunodeficiency virus type 1 proviral DNA and human DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

New developments in diketo-containing inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Coumarin-based inhibitors of HIV integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2956007-2

7 January 2021

10.1016/S1054-3589(07)56007-2

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18086413